Vero cells were infected with SARS-CoV-2 at a MOI of 0.1 in 96-well plates for 24 h. The cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton X-100, and blocked with 5% BSA. The 1:100 diluted human plasma samples were used as the primary antibody. Alexa Fluor 488-labeled anti-human IgG (Life Technologies, Eugene, OR, USA) was used as the secondary antibody. The nuclei were stained with DAPI (Sigma-Aldrich). The images were obtained by scanning with an Operetta High Content Screening system (PerkinElmer, Waltham, MA, USA) and the number of SARS-CoV-2 infected Vero cells and fluorescent intensity were quantified by using the same software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.